Resistant hypertension optimal treatment trial: a randomized controlled trial.  [electronic resource] 

 -  Clinical cardiology  Jan 2014 
 - 1-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-8737 
<br/><br/><label>Standard No.: </label>10.1002/clc.22228  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-2 Receptor Agonists--therapeutic use<br/>Aged<br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Antihypertensive Agents--therapeutic use<br/>Blood Pressure--drug effects<br/>Brazil--epidemiology<br/>Calcium Channel Blockers--therapeutic use<br/>Clinical Protocols<br/>Clonidine--therapeutic use<br/>Diuretics--therapeutic use<br/>Drug Discovery<br/>Drug Resistance<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Hypertension--diagnosis<br/>Male<br/>Medication Adherence<br/>Middle Aged<br/>Mineralocorticoid Receptor Antagonists--therapeutic use<br/>Prevalence<br/>Research Design<br/>Spironolactone--therapeutic use<br/>Time Factors<br/>Treatment Outcome